🇺🇸 FDA
Patent

US 6569897

Alkenyldiarylmethane non-nucleoside HIV-1 reverse transcriptase inhibitors

expired A61PA61P31/12A61P31/18

Quick answer

US patent 6569897 (Alkenyldiarylmethane non-nucleoside HIV-1 reverse transcriptase inhibitors) held by The United States of America, as represented by the Department of Health and Human Services expires Mon May 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue May 27 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61P, A61P31/12, A61P31/18, A61P43/00